A Study of PF08634404 With or Without Enfortumab Vedotin in People With Urothelial Cancer

Full Title

An Interventional Phase 1b/2, Open-Label Study to Investigate the Tolerability, Antitumor Activity, and Pharmacokinetics of PF08634404 Monotherapy or in Combination with Enfortumab Vedotin in Adult Participants with Locally Advanced or Metastatic Urothelial Cancer

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Scot Niglio’s office at 646-823-4790. 

Protocol
26-378
Phase
Phase I/II (phases 1 and 2 combined)
Investigator
Scot Niglio
Co-Investigators
Jonathan E. Rosenberg
Diseases
Genitourinary Cancer › Bladder Cancer
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT07421700
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description